Commercial Credit Report for Gubra A/S

CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals. Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue. We also offer solutions that can help ease private company financial risk assessment. Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively.

A partial report preview for Gubra A/S is shown below. Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database. To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

	Gubra A/S
Hoersholm Kongevej 11 B
	HOERSHOLM, 2970 Denmark	Ticker: GUBRAGUBRA

Business Summary

Gubra A/S is a Denmark-based biotechnology company specialized in high-end pre-clinical contract research and peptide-based drug discovery within metabolic and fibrotic diseases. The Company’s operations are anchored around its advanced technology platforms and utilization of automation, robotization and digitalization, including machine learning (ML) and artificial intelligence (AI). The Company's business activity are divided into two segments: The CRO Segment offers specialized profitable pre-clinical contract research services at attractive margins within metabolic and fibrotic disease areas such as diabetes, obesity, chronic kidney disease; and The Discovery and Partnership Segment is based on an internal target and drug discovery engine for identification and design of peptide-based drug partnering candidates within metabolic and fibrotic diseases.

Scores and Ratings

FRISK^® Score	Z'' Score	PAYCE^® Score	DBT Index	Moody's Rating	Fitch Rating	DBRS Rating
Yes	Yes	-	-	-	-	-

Financials, News and Filings

Latest Statement	Last Audit	News	SEC Filings	Bankruptcy Filings	Suit & Judgment Filings	Tax Lien Filings
12/31/2023	12/31/2023	Yes	-	-	-	-

Industries

SIC Code	Description
8731	Commercial physical and biological research
2834	Pharmaceutical preparations

Officers and Directors

Title	Name	Age	Title Date	Start Date
Chairman of the Board, Co-Founder	JacobJelsing	49	5/23/2022	10/1/2008
Chief Executive Officer	HenrikBlou	44	6/1/2016	6/1/2016
Independent Deputy Chairman of the Board	Alexander T.Martensen-Larsen	47	5/23/2022	1/21/2022
4 additional Officers and Directors records available in full report.

Subsidiaries

Business Name	Address	City	State/Province	Country
MiniGut ApS	Dr Neergaards Vej 3	H?rsholm		DK

Business Names

Business Name
GUBRA
MiniGut ApS

General Information

Number of Employees:	219	(As of 12/31/2023)
Outstanding Shares:	16,290,432	(As of 12/31/2023)
Stock Exchange:	CPH

SITE MAP | ABOUT US | DIRECTORY | STOCK QUOTE: CRMZ | SIGN IN